Price
Target price
€18.15
€18.15
-3.080%
-0.582
-3.080%
€18.80
14.11.25 / Tradegate
WKN: A2N6BH / Symbol: ELAN / Name: Elanco Animal Health / Stock / Pharmaceuticals / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Elanco Animal Health Inc. Stock
Heavy losses for Elanco Animal Health Inc. today as the stock fell by -€0.582 (-3.080%).
With 17 Buy predictions and not the single Sell prediction the community is currently very high on Elanco Animal Health Inc..
However, we have a potential of -0.85% for Elanco Animal Health Inc. as the target price of 18 € is below the current price of 18.15 €.
Pros and Cons of Elanco Animal Health Inc. in the next few years
Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
B****
?
C******** o* t** e**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Elanco Animal Health Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Elanco Animal Health Inc. | -3.080% | -2.282% | 4.166% | 36.537% | 57.205% | 45.511% | -28.766% |
| Johnson & Johnson | 0.980% | 4.538% | 2.579% | 16.835% | 21.254% | 1.297% | 33.081% |
| Biogen Inc. | 2.400% | 7.326% | 15.210% | -7.913% | 0.174% | -50.155% | -31.416% |
| Pfizer Inc. | -2.680% | 2.130% | 2.106% | -12.738% | -14.939% | -54.778% | -30.229% |
Comments
Elanco Animal Health (NYSE:ELAN) had its price target raised by analysts at UBS Group AG from $25.00 to $27.00. They now have a "buy" rating on the stock.
Show more
Ratings data for ELAN provided by MarketBeat
Elanco Animal Health (NYSE:ELAN) was downgraded by analysts at Wall Street Zen from a "strong-buy" rating to a "buy" rating.
Show more
Ratings data for ELAN provided by MarketBeat
Elanco Animal Health (NYSE:ELAN) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $24.00 price target on the stock, up previously from $18.00.
Show more
Ratings data for ELAN provided by MarketBeat
